Clinical Oncology
Volume 18, Issue 9 , Pages 669-677 , November 2006

Clinicopathological Review of 61 Patients with Early Bile Duct Cancer

  • J.M. Cha

      Affiliations

    • Department of Internal Medicine, East–West Neo Medical Center, University of Kyunghee College of Medicine, Seoul, Republic of Korea
    • ,
  • M.H. Kim

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • Corresponding Author InformationAuthor for correspondence: Myung-Hwan Kim, PhD, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Republic of Korea. Tel: +82-2-3010-3180.
    • ,
  • S.K. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • ,
  • D.W. Seo

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • ,
  • S.S. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • ,
  • J.H. Lee

      Affiliations

    • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • ,
  • S.G. Lee

      Affiliations

    • Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    • ,
  • S.J. Jang

      Affiliations

    • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Received 12 March 2006 ,Revised 19 June 2006 ,Accepted 3 July 2006.

References 

  1. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology. 2005;128:1655–1667
  2. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology. 2004;66:167–179
  3. Anthony PP. Tumors and tumor-like lesions of the liver and biliary tract: aetiology, epidemiology and pathology. In:  McSween RNM,  Burt AD,  Portmann BC,  Ishak KG,  Scheuer PJ,  Anthony PP editor. Pathology of the liver. 4th edn. Edinburgh: Churchill Livingstone; 2002;p. 743–747
  4. Lim JH. Cholangiocarcinoma: recent advances in imaging and intervention. Abdom Imaging. 2004;29:538–539
  5. Tamada K, Tomiyama T, Wada S, et al. Cholangiographic findings of early-stage extrahepatic bile duct carcinoma. J Gastroenterol. 2001;36:827–841
  6. Tsunoda T, Eto T, Koga M, et al. Early carcinoma of the extrahepatic bile duct. Jpn J Surg. 1989;19:691–698
  7. Mizumoto R, Ogura Y, Kusuda T. Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterology. 1993;40:69–77
  8. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002;17:1049–1055
  9. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–475
  10. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis. 2002;22:213–226
  11. Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y. Th1 cytokine-induced downregulation of PPARγ in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology. 2005;41:1329–1338
  12. Liver Cancer Study Group of Japan . The general rules for the clinical and pathological study of primary liver cancer. 4th edn. Tokyo: Kanehara; 2000;
  13. Bhuiya MMB, Nimura Y, Kamiya J, Kondo S, Nagino M, Hayakawa N. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg. 1993;17:653–657
  14. Kurosaki I, Tsukada K, Watanabe H, et al. Prognostic determinants in extrahepatic bile duct cancer. Hepatogastroenterology. 1998;45:905–909
  15. Hidaka E, Yanagisawa A, Makoto S, Takano K, Kato H. The opinions from the standpoint of pathology concerning. “General rules for surgical and pathological studies on cancer of the biliary tract, 4th edn”. Kan Tan Sui. 2000;41:543–550(In Japanese)
  16. Farley DR, Donohue JH, Nagorney DM, Carpenter HA, Katzmann JA, Ilstrup DM. Early gastric cancer. Br J Surg. 1992;79:539–542
  17. Percivale P, Bertoglio S, Muggianu M, et al. Long-term postoperative results in 54 cases of early gastric cancer: the choice of surgical procedure. Eur J Surg Oncol. 1989;15:436–440
  18. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002;89:962–970
  19. Shin HR, Lee DH, Park HJ, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case–control study in Pusan, Korea. Int J Epidemiol. 1996;25:933–940
  20. Lee SS, Kim MH, Lee SK, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer. 2004;100:783–793
  21. Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet. 2005;366:1303–1314
  22. De Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368–1378
  23. Kim JE, Lee KT, Lee JK, Paik SW, Rhee JC, Choi KW. Clinical usefulness of cancer antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004;19:182–186
  24. Stains S, Parekh D, Selby R. Tumors of the gallbladder and the biliary tract. In:  Kaplowitz N editors. Liver and biliary disease. 2nd edn. Baltimore: Williams and Wilkins; 1996;p. 730–734
  25. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Cancer. 1992;70:1498–1501
  26. Takehara Y. Preoperative assessment of extrahepatic cholangiocarcinoma with imaging. Abdom Imaging. 2004;29:572–580
  27. Zandrino F, Curone P, Benzi L, et al. MR versus multislice CT cholangiography in evaluating patients with obstruction of the biliary tract. Abdom Imaging. 2005;30:77–85
  28. Rosai T. Ackerman's surgical pathology. 8th edn. St Louis: Mosby; 1994;
  29. Kozuka S, Tsubone M, Hachisuka K. Evolution of carcinoma in the extrahepatic bile ducts. Cancer. 1984;54:65–72
  30. Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132:555–564
  31. Jan YY, Jeng LB, Hwang TL, Wang CS, Chen MF, Chen TJ. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology. 1996;43:614–619
  32. Lieser MJ, Barry MK, Rowland C, Ilstrup DM, Nagorney DM. Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg. 1998;5:41–47
  33. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish WM, Thomas S. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227:70–79
  34. Morimoto Y, Tanaka Y, Ito Y, et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10:432–440
  35. Klempnaur J, Ridder GJ, Werner M, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma?. Cancer. 1997;79:26–34
  36. Gerhards MF, van Gulik TM, Bosma A, et al. Long-term survival after resection of proximal bile duct carcinoma. World J Surg. 1999;23:91–96
  37. Tomoo K, Junji Y, Kazuaki S, Susumu Y, Masatoshi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg. 1999;230:663–671
  38. Wade TP, Prasad CN, Virgo KS, Johnson FE. Experiences with distal bile duct cancers in Veterans Affairs Hospitals: 1987–1991. J Surg Oncol. 1997;64:242–245
  39. Joo YH, Myung SJ, Kim MH, et al. Clinical study on 193 cases of extrahepatic bile duct carcinoma and its prognostic factors. Korean J Gastroenterol. 1999;33:114–123(In Korean)

PII: S0936-6555(06)00231-7

doi: 10.1016/j.clon.2006.07.005

Clinical Oncology
Volume 18, Issue 9 , Pages 669-677 , November 2006

Article Tools

* Image Usage & Resolution